Manning & Napier Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Manning & Napier Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-71,755	Closed	-$8.11M	–	331
2017 Q2	$8.11M	Sell	71,755 -10,570	-13%	-$1.18M	0.07%	133
2017 Q1	$8.24M	Sell	82,325 -7,575	-8%	-$809K	0.06%	133
2016 Q4	$9.66M	Buy	89,900 +9,550	+12%	+$1.12M	0.06%	125
2016 Q3	$10M	Buy	80,350 +28,050	+54%	+$3.31M	0.06%	119
2016 Q2	$5.56M	Buy	+52,300	New	+$6.07M	0.03%	189

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Manning & Napier Advisors's CBPO Position: Q3 2017 in Review

Manning & Napier Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 71,755 shares — an estimated $8.11M sold.

Manning & Napier Advisors first reported a position in CBPO in Q2 2016 and held it in 5 quarters. The position peaked at $10M in Q3 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

Manning & Napier Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
Manning & Napier Advisors sold 71,755 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $8.11M.
Manning & Napier Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 5 quarters.
Manning & Napier Advisors's China Biologic Products Holdings, Inc. position peaked at $10M in Q3 2016.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Manning & Napier Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.